Psychedelics Investing

Dried mushrooms and capsules aligned on a light surface.

Psychedelics Market Update: H1 2025 in Review

Discover what's been driving growth in the psychedelics market, and what may be next for this emerging healthcare sector.

Psychedelics Investing
Latest Articles

US Policy Momentum, Clinical Progress Fueling Psychedelics Market in 2025

Psychedelics Investing

Psychedelics Market Forecast: Top Trends for Psychedelics in 2025

Psychedelics Investing

FDA Finds Kratom Capsules Safe, but Questions About Concentrated Forms Remain

Psychedelics Investing

Psychedelics Market Update: H1 2024 in Review

Psychedelics Investing

Psychedelics Market Forecast: Top Trends That Will Affect Psychedelics in 2024

Psychedelics Investing

Psychedelics Market 2023 Year-End Review

Psychedelics Investing
Company Profiles
More Companies
CEO Interviews

Silo Wellness CEO Sees Market Traction for Psychedelic Healing

Psychedelics Investing

Orphan Drug Development an Exciting Opportunity to Provide Superior Therapeutics, Lobe Sciences CEO Says

Psychedelics Investing

Albert Labs Eyes One Dose Psilocybin Treatment for Cancer-related Anxiety

Psychedelics Investing
psychedelics News

Quantum Biopharma Announces Completion of the Phase 1 Multiple Ascending Dose Clinical Trial for its Experimental Multiple Sclerosis Drug Lucid-21-302

SmartNews
Fungtional Labs

Fungtional Labs: Integrated Supply Chain for Mushroom Cultivators in North America

Psychedelics Investing

Lobe Sciences Provides Update on L-130 Clinical Program

Psychedelics Investing

Lobe Sciences Provides Update on L-130 Oral Psilocin Compound

Psychedelics Investing

TSX Venture Exchange Stock Maintenance Bulletins

Psychedelics Investing
Lobe Sciences (CSE:LOBE)

Lobe Sciences, Ltd. Announces The Appointment Of Mathew Lee As CFO

Psychedelics Investing
Lobe Sciences (CSE:LOBE)

Lobe Sciences, Ltd. Announces Amendment to the Acquisition of Altemia & Company

Psychedelics Investing
Silo Wellness (CSE:SILO)

Silo Wellness Announces LOI to Acquire NUGL/Kaya in a Transaction Valued at CAD $43,289,624.60; CSE to Halt Trading Until Shareholder Approval

Psychedelics Investing
Silo Wellness (CSE:SILO)

Milestone in Psychedelic Wellness: Silo Wellness and NUGL's Share Exchange Paves Way for Expansion and Collaboration

Psychedelics Investing
Silo Wellness (CSE:SILO)

Jamaica Based Kaya Group Forges Partnership with Silo Wellness for Psychedelic Wellness Experiences and Retreats; Announces Share Exchange Agreement

Psychedelics Investing
International
Emyria Limited (ASX:EMD)

Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

Psychedelics Investing
Melodiol Global Health (ASX:ME1)

Quarterly Activities Report: Melodiol Delivers $9.3m in Revenue During H1 FY24 – a 33% Increase the PCP

SmartNews
Melodiol Global Health Limited (ASX:ME1)

Corporate Update

Psychedelics Investing
Melodiol Global Health Limited (ASX:ME1)

Melodiol Global Health Limited (ASX: ME1) – Trading Halt

Psychedelics Investing
Melodiol Global Health Limited (ASX:ME1)

Mernova Q3 Revenue Update

Psychedelics Investing
More psychedelics News
Editors' Picks
Psychedelics Investing

Psychedelics Market Forecast: 3 Top Trends That Will Affect Psychedelics in 2023

Psychedelics Investing

Psychedelics Market 2022 Year-End Review

Psychedelics Investing

How Do Psychedelics Clinical Trials Work?

Latest psychedelics News

More psychedelics News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×